规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Mitochondrial dysfunction is involved in the pathogenesis of chronic kidney disease and acute kidney injury (AKI). Mitochonic acid 5 (MA-5) is a synthesized indole acetic acid derivative that facilitates ATP production, reduces the level of mitochondrial reactive oxygen species, and targets mitochondrial protein mitofilin. MA-5 binds to mitofilin with a Bmax value of 12.5±4.35ng and a Kd value of 28.2±11.4µM[1]. MA-5 at 1-10µM dose-dependently inhibited TNFα-induced apoptosis in mouse microglial BV-2 cells. Treatment with MA-5 at 5µM increased mitochondrial potential and decreased the level of mitochondrial calcium in TNFα-treated cells[2]. In a bilateral ischemia-reperfusion injury (IRI) model, oral administration of MA-5 at 25, 50, or 150mg/kg significantly improved plasma creatinine level after reperfusion compared to the vehicle-treated IRI mice. MA-5 treatment also significantly decreased the expression of AKI marker, KIM-1, at the outer medullar and the acute tubular necrosis score in IRI mice at 48h post-treatment. In a mouse model of cisplatin-induced nephropathy (CIN), MA-5 (50mg/kg)-treated mice showed significantly reduced plasma BUN 96h after cisplatin administration compared to the vehicle-treated CIN animals[1]. |
作用机制 | Mitochonic acid 5 is a synthesized indole derivative that regulates mitochondrial ATP synthesis independently of electron transport chain and oxidative phosphorylation[1]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.04mL 0.61mL 0.30mL |
15.18mL 3.04mL 1.52mL |
30.37mL 6.07mL 3.04mL |
CAS号 | 1354707-41-7 |
分子式 | C18H13F2NO3 |
分子量 | 329.3 |
SMILES Code | O=C(O)C(CC(C1=CC=C(F)C=C1F)=O)C2=CNC3=C2C=CC=C3 |
MDL No. | MFCD31657404 |
别名 | MA-5 |
运输 | 蓝冰 |
InChI Key | BOKQALWNGNLTOC-UHFFFAOYSA-N |
Pubchem ID | 76070959 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry, 2-8°C |
溶解方案 |
DMSO: 105 mg/mL(318.86 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|